India to Canada: Pravastatin Export Trade Route

The India to Canada Pravastatin corridor is one of India's established pharmaceutical export routes, with 154 shipments documented worth a combined $7.4M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 82% of all export value, reflecting the consolidated nature of India's pravastatin manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $47.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with pravastatin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 26.6%, placing it at rank #20 among India's top pravastatin export destinations globally.

On the import side, key buyers of Indian pravastatin in Canada include MANTRA DISTRIBUTIONS INC, APOTEX INC, MARCAN PHARMACEUTICALS INC., and 15 others. MANTRA DISTRIBUTIONS INC is the single largest importer with 4 shipments valued at $6.0M USD.

India's pravastatin exports to Canada are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LIMITED, APOTEX RESEARCH PRIVATE LIMITED — together account for 96% of total trade value on this route. The average shipment value of $47.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ph.dru.& med.: pr m-pravastatin tablets40mg (each tablet cont. pravastatin sodium ph.eur. 40mg) [1x100t per pack] and ph.dru.& med.: pr m-pravastatin tablets10mg (each tablet cont. pravastatin sodium ph.eur. 10mg) [1x100t per pack], suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MANTRA DISTRIBUTIONS INC is the largest importer with 4 shipments worth $6.0M USD — representing 82% of all pravastatin imports from India on this route. A total of 18 buyers are active on this corridor.